CABALETTA BIO INC
CABA·12674W109·US·Common Stock·Healthcare - Biotechnology-13D/G
CABA (CABALETTA BIO INC) is held by 68 institutional investors as of Q1 2026. Largest holders: JENNISON ASSOCIATES LLC ($24.1M), ADAGE CAPITAL PARTNERS GP, L.L.C. ($23.8M), MILLENNIUM MANAGEMENT LLC ($15.9M). Net institutional sentiment: Mixed.
68
Holders
Avg rating(12 Elite)
$136.7M
Total Value
63% (75)
Fund Consensus
40 buying - 24 selling
Who's Trading
ActivistCACormorant Asset Management, LP9.0%May 15, 2026
ActivistTRT. Rowe Price Investment Management, Inc.10.2%Feb 17, 2026
InsiderNSNichtberger StevenBuy $101KJan 21, 2026
InsiderSMSimon MarkBuy $25KJan 21, 2026
InsiderBGBinder GwendolynBuy $25KJan 21, 2026
InsiderTSTomasello ShawnBuy $50KJan 21, 2026
13F: Insider & Congress:
Showing 1-20 of 75
1 / 4
Continue exploring
Other Healthcare stocks held by institutions
LLYELI LILLY & CO
413 holders · $666.6B
UNHUNITEDHEALTH GROUP INC413 holders · $186.3B
JNJJOHNSON & JOHNSON394 holders · $391.3B
DHRDANAHER CORP DEL392 holders · $97B
ISRGINTUITIVE SURGICAL INC391 holders · $123.5B
TMOTHERMO FISHER SCIENTIFIC INC391 holders · $147B
BSXBOSTON SCIENTIFIC CORP389 holders · $76.8B
MRKMERCK & CO INC385 holders · $208.9B
ABBVABBVIE INC381 holders · $254.9B
ABTABBOTT LABORATORIES380 holders · $129.1B
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer